Literature DB >> 12199113

[In vitro resistance acquisition in Mycoplasma gallisepticum against ofloxacin, tylosin and spectinomycin].

Isamu Takahashi1, Takaharu Yoshida, Yoshihiro Higashide, Takuo Sawada.   

Abstract

To clarify a mechanism of acquired resistance of two Mycoplasma gallisepticum (MG) strains against ofloxacin (OFLX) along with tylosin (TS) and spectinomycin (SPCM) as the controls, in vitro resistance acquisition test was carried out for 10 subcultures of each strain with increasing the amount of antimicrobials, and maximum growth allowance concentrations (MAC) in 10th and primary subcultures were compared. Acquisition of resistance in the strains against OFLX was moderate and MAC of the 10th subculture increased twice for one strain and 16 times for another one as compared to that of their primary subcultures. Acquisition of resistance in the strains against TS was also moderate and MAC of the 10th subculture increased 8 times for both strains as compared to that of the primary subcultures. Acquisition of resistance against SPCM was quite different between the strains. Namely the MAC of one strain increased 512 times, while another one did not acquire any resistance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12199113

Source DB:  PubMed          Journal:  Jpn J Antibiot        ISSN: 0368-2781


  2 in total

1.  Antibiotic susceptibility profiles of Mycoplasma synoviae strains originating from Central and Eastern Europe.

Authors:  Zsuzsa Kreizinger; Dénes Grózner; Kinga M Sulyok; Kristin Nilsson; Veronika Hrivnák; Dušan Benčina; Miklós Gyuranecz
Journal:  BMC Vet Res       Date:  2017-11-17       Impact factor: 2.741

2.  Proteomic analysis of tylosin-resistant Mycoplasma gallisepticum reveals enzymatic activities associated with resistance.

Authors:  Xi Xia; Congming Wu; Yaowen Cui; Mengjiao Kang; Xiaowei Li; Shuangyang Ding; Jianzhong Shen
Journal:  Sci Rep       Date:  2015-11-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.